Sign in
4

Changes in Ownership

Bionano Genomics, Inc. Filed Acc 0001209191-21-024792

Options or other derivatives

  • Chief Medical Officer acquired 275,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Chaubey Alka Chief Medical Officer 2021-04-01 Grant or award · Stock Option (Right to Buy) +275,000 275,000 D
Loading xslF345X03/doc4.xml…